Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,160.00    -20.00 (-1.69%)
Bid:
1,161.00
Ask:
1,200.00
Spread: 39.00 (3.359%)
Market Cap: £806.69m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Option exercise and block listing update

31 Jan 2020 17:47

RNS Number : 6508B
CVS Group plc
31 January 2020
 

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Confirmation of Cancellation of Block Listing

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that certain employees have exercised options under the Company's Save As You Earn (SAYE) 2020 scheme (the "SAYE Exercise") totalling 66,249 ordinary shares of 0.2 pence each ("Ordinary Shares") during January.

The SAYE Exercise was satisfied out of the Company's existing Employee Benefit Trust ("EBT") which was first announced on 28 February 2017. As at the date of this announcement, the remaining number of ordinary shares held by the EBT is 72,519.

The Company also announces that its 2015/2018 Save as You Earn option scheme has closed and, as a result, the block listing associated with it has been cancelled. Since the block listing interim review dated 24 June 2019, the Company issued a total of 24,335 shares in satisfaction of the exercise of SAYE options. All such issuance has been previously announced. The Company has no other block listings.

The Company's total issued share capital at the date of this announcement therefore remains unchanged at 70,654,959 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,654,959. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Name of applicant:

CVS Group plc

Name of scheme:

2015/2018 Save as You Earn Scheme

Period of return:

From:

23 June 2019

To:

30 December 2019

Balance of unallotted securities under scheme(s) from previous return:

136,632

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

24,335

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

112,297

Subsequent cancellation:

(112,297)

Equals: Remaining balance under block listing

Nil

 

Contacts:

CVS Group Plc Tel: 01379 644288

Richard Fairman, Chief Executive Officer

David Harris, Company Secretary

 

N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSDMFWFESSELF
Date   Source Headline
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update
19th Nov 20214:26 pmRNSHolding(s) in Company
10th Nov 202111:17 amRNSHolding(s) in Company
3rd Nov 20212:30 pmRNSPCA Shareholding
1st Nov 20218:00 amRNSHolding(s) in Company
29th Oct 202110:17 amRNSPosting of Annual Report & Notice of AGM
29th Oct 20217:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20216:01 pmRNSExercise of Options, PDMR Dealing and TVR
7th Oct 20211:52 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSLong Term Incentive Plan Awards & PDMR Dealing
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
29th Sep 20215:28 pmRNSHolding(s) in Company
28th Sep 20217:54 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSBoard Changes
23rd Sep 20217:00 amRNSFinal results for the year ended 30 June 2021
13th Sep 20211:50 pmRNSHolding(s) in Company
31st Aug 20217:00 amRNSExercise of Options and Total Voting Rights
27th Aug 20215:34 pmRNSHolding(s) in Company
26th Aug 20218:48 amRNSBlock Listing Application
24th Aug 20214:10 pmRNSHolding(s) in Company
20th Aug 20212:09 pmRNSHolding(s) in Company
20th Aug 20212:07 pmRNSHolding(s) in Company
30th Jul 202112:00 pmRNSExercise of Options and Total Voting Rights
29th Jul 20214:14 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTrading Update
13th Jul 202112:40 pmRNSBlock Listing Interim Review and TVR Update
30th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
28th May 202112:00 pmRNSExercise of Options and Total Voting Rights
13th May 20218:30 amRNSShareholder Consultation regarding 2020 AGM
30th Apr 202112:00 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSTrading Update
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20219:06 amRNSDirector/PDMR and PCA Shareholding
25th Mar 20217:00 amRNSInterim Results
3rd Mar 20217:30 amRNSHolding(s) in Company
26th Feb 202112:00 pmRNSExercise of Options and Total Voting Rights
5th Feb 20214:30 pmRNSHolding(s) in Company
29th Jan 202112:00 pmRNSExercise of Options
29th Jan 20217:00 amRNSTrading Update
6th Jan 20219:30 amRNSBlock Listing Application
5th Jan 20217:00 amRNSLong Term Incentive Plan Award
31st Dec 20207:00 amRNSExercise of Options
4th Dec 20209:34 amRNSGrant of Options under SAYE Scheme & PDMR Dealing
26th Nov 20203:49 pmRNSResult of AGM
26th Nov 20207:00 amRNSAGM Statement and Trading Update
23rd Nov 20207:00 amRNSHolding(s) in Company
9th Nov 20201:32 pmRNSLong Term Incentive Plan Awards & PDMR Dealing
6th Nov 20201:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.